Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole IR vs placebo in children and adolescents with Tourette disorder
2008-004460-39Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Tourette syndrome (TS) comparing Pramipexole IR with Placebo (2 arms). Primary endpoint: Change in YGTSS total tic score from baseline to week 6. Started Sep 2008; status: completed.
02
Drugs
pramipexole
03
Conditions
Tourette syndrome (TS)
Beyond the preview
Go deeper on 2008-004460-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004460-39.